Dendreon

Dendreon

Biotechnology Research

Seal Beach , CA 33,923 followers

Pioneering the future of immunotherapy.

About us

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
Seal Beach , CA
Type
Privately Held
Founded
1992
Specialties
Oncology, Cancer Treatment, Immunotherapy, Cellular Immunotherapy, Urology, CMO, and Contract Manufacturing

Locations

Employees at Dendreon

Updates

Similar pages

Browse jobs